← FDA Drug Approvals (Drugs@FDA)
FLUDEOXYGLUCOSE F18
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UNIV TX MD ANDERSON · Approved 2014-01-13
Drug application
- FDA Application #
ANDA203246- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUDEOXYGLUCOSE F18
- Generic name
- FLUDEOXYGLUCOSE F18
- Active ingredients
- FLUDEOXYGLUCOSE F-18
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- UNIV TX MD ANDERSON
- Manufacturer
- The University of Texas MD Anderson Cancer Center
- First approval
- 2014-01-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown